BENJAMIN R.
- Country
- France
- Department
- 69
Research Overview
- Efficacy of High‑Dose vs Low‑Dose Psilocybin for Relapse Prevention in Severe Alcohol Use Disorder with Comorbid Depression: Randomized Controlled Trial
- NAlmefene versus placebo in addition to treatment as usual on craving in Behavioural Addictions (NABAb)
- Evaluation of Sodium Oxybate for Reducing Alcohol Consumption and Sustaining Abstinence in Patients with Alcohol Dependence at High Drinking Risk Levels
Data & Insights
Has run more than one trial at 6 of 39 partner sites.
Specializations
Substance Use Disorders
The investigator specializes in treating alcohol dependency and benzodiazepine use disorder, exploring innovative therapeutic approaches for substance abuse treatment.
- Alcohol consumption reduction strategies
- Benzodiazepine dependence management
- Novel pharmacological interventions
Key focus includes evaluating the effectiveness of medications like sodium oxybate and cannabidiol in treating alcohol use disorders.
Behavioral Addictions
Expertise extends to treating various forms of behavioral addictions, including gambling disorder, sexual addiction, and food addiction.
- Craving management techniques
- Addiction-specific interventions
- Combined treatment approaches
Investigates pharmacological solutions using nalmefene alongside standard therapeutic protocols for behavioral addiction treatment.
Psychiatric Medicine
Focuses on the intersection of psychiatric disorders and addiction medicine, developing comprehensive treatment strategies for dual diagnosis patients.
- Integrated treatment approaches
- Medication-assisted therapy
- Psychiatric comorbidity management
Explores therapeutic interventions that address both psychological and addictive aspects of mental health conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.